HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter.

AuthorsSteen J Bonnema, Viveque E Nielsen, Laszlo Hegedüs
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 88 Issue 12 Pg. 6113-4; author reply 6114-5 (Dec 2003) ISSN: 0021-972X [Print] United States
PMID14671219 (Publication Type: Comment, Letter)
Chemical References
  • Iodine Radioisotopes
  • Recombinant Proteins
  • Thyrotropin
Topics
  • Dose-Response Relationship, Radiation
  • Goiter, Nodular (drug therapy, radiotherapy)
  • Humans
  • Iodine Radioisotopes (administration & dosage)
  • Premedication
  • Recombinant Proteins (therapeutic use)
  • Thyrotropin (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: